Cargando…

Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates

BACKGROUND: With the use of broad-spectrum antibiotics, immunosuppressive drugs, and glucocorticoids, multidrug-resistant Acinetobacter baumannii (MDR-AB) has become a major nosocomial pathogen species. The recent renaissance of bacteriophage therapy may provide new treatment strategies for combatti...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Fan, Mi, Zhiqiang, Huang, Yong, Yuan, Xin, Niu, Wenkai, Wang, Yahui, Hua, Yuhui, Fan, Huahao, Bai, Changqing, Tong, Yigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094691/
https://www.ncbi.nlm.nih.gov/pubmed/24996449
http://dx.doi.org/10.1186/1471-2180-14-181
_version_ 1782325881589465088
author Peng, Fan
Mi, Zhiqiang
Huang, Yong
Yuan, Xin
Niu, Wenkai
Wang, Yahui
Hua, Yuhui
Fan, Huahao
Bai, Changqing
Tong, Yigang
author_facet Peng, Fan
Mi, Zhiqiang
Huang, Yong
Yuan, Xin
Niu, Wenkai
Wang, Yahui
Hua, Yuhui
Fan, Huahao
Bai, Changqing
Tong, Yigang
author_sort Peng, Fan
collection PubMed
description BACKGROUND: With the use of broad-spectrum antibiotics, immunosuppressive drugs, and glucocorticoids, multidrug-resistant Acinetobacter baumannii (MDR-AB) has become a major nosocomial pathogen species. The recent renaissance of bacteriophage therapy may provide new treatment strategies for combatting drug-resistant bacterial infections. In this study, we isolated a lytic bacteriophage vB_AbaM-IME-AB2 has a short latent period and a small burst size, which clear its host’s suspension quickly, was selected for characterization and a complete genomic comparative study. RESULTS: The isolated bacteriophage vB_AbaM-IME-AB2 has an icosahedral head and displays morphology resembling Myoviridae family. Gel separation assays showed that the phage particle contains at least nine protein bands with molecular weights ranging 15–100 kDa. vB_AbaM-IME-AB2 could adsorb its host cells in 9 min with an adsorption rate more than 99% and showed a short latent period (20 min) and a small burst size (62 pfu/cell). It could form clear plaques in the double-layer assay and clear its host’s suspension in just 4 hours. Whole genome of vB_AbaM-IME-AB2 was sequenced and annotated and the results showed that its genome is a double-stranded DNA molecule consisting of 43,665 nucleotides. The genome has a G + C content of 37.5% and 82 putative coding sequences (CDSs). We compared the characteristics and complete genome sequence of all known Acinetobacter baumannii bacteriophages. There are only three that have been sequenced Acinetobacter baumannii phages AB1, AP22, and phiAC-1, which have a relatively high similarity and own a coverage of 65%, 50%, 8% respectively when compared with our phage vB_AbaM-IME-AB2. A nucleotide alignment of the four Acinetobacter baumannii phages showed that some CDSs are similar, with no significant rearrangements observed. Yet some sections of these strains of phage are nonhomologous. CONCLUSION: vB_AbaM-IME-AB2 was a novel and unique A. baumannii bacteriophage. These findings suggest a common ancestry and microbial diversity and evolution. A clear understanding of its characteristics and genes is conducive to the treatment of multidrug-resistant A. baumannii in the future.
format Online
Article
Text
id pubmed-4094691
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40946912014-07-13 Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates Peng, Fan Mi, Zhiqiang Huang, Yong Yuan, Xin Niu, Wenkai Wang, Yahui Hua, Yuhui Fan, Huahao Bai, Changqing Tong, Yigang BMC Microbiol Research Article BACKGROUND: With the use of broad-spectrum antibiotics, immunosuppressive drugs, and glucocorticoids, multidrug-resistant Acinetobacter baumannii (MDR-AB) has become a major nosocomial pathogen species. The recent renaissance of bacteriophage therapy may provide new treatment strategies for combatting drug-resistant bacterial infections. In this study, we isolated a lytic bacteriophage vB_AbaM-IME-AB2 has a short latent period and a small burst size, which clear its host’s suspension quickly, was selected for characterization and a complete genomic comparative study. RESULTS: The isolated bacteriophage vB_AbaM-IME-AB2 has an icosahedral head and displays morphology resembling Myoviridae family. Gel separation assays showed that the phage particle contains at least nine protein bands with molecular weights ranging 15–100 kDa. vB_AbaM-IME-AB2 could adsorb its host cells in 9 min with an adsorption rate more than 99% and showed a short latent period (20 min) and a small burst size (62 pfu/cell). It could form clear plaques in the double-layer assay and clear its host’s suspension in just 4 hours. Whole genome of vB_AbaM-IME-AB2 was sequenced and annotated and the results showed that its genome is a double-stranded DNA molecule consisting of 43,665 nucleotides. The genome has a G + C content of 37.5% and 82 putative coding sequences (CDSs). We compared the characteristics and complete genome sequence of all known Acinetobacter baumannii bacteriophages. There are only three that have been sequenced Acinetobacter baumannii phages AB1, AP22, and phiAC-1, which have a relatively high similarity and own a coverage of 65%, 50%, 8% respectively when compared with our phage vB_AbaM-IME-AB2. A nucleotide alignment of the four Acinetobacter baumannii phages showed that some CDSs are similar, with no significant rearrangements observed. Yet some sections of these strains of phage are nonhomologous. CONCLUSION: vB_AbaM-IME-AB2 was a novel and unique A. baumannii bacteriophage. These findings suggest a common ancestry and microbial diversity and evolution. A clear understanding of its characteristics and genes is conducive to the treatment of multidrug-resistant A. baumannii in the future. BioMed Central 2014-07-05 /pmc/articles/PMC4094691/ /pubmed/24996449 http://dx.doi.org/10.1186/1471-2180-14-181 Text en Copyright © 2014 Peng et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Peng, Fan
Mi, Zhiqiang
Huang, Yong
Yuan, Xin
Niu, Wenkai
Wang, Yahui
Hua, Yuhui
Fan, Huahao
Bai, Changqing
Tong, Yigang
Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
title Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
title_full Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
title_fullStr Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
title_full_unstemmed Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
title_short Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
title_sort characterization, sequencing and comparative genomic analysis of vb_abam-ime-ab2, a novel lytic bacteriophage that infects multidrug-resistant acinetobacter baumannii clinical isolates
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094691/
https://www.ncbi.nlm.nih.gov/pubmed/24996449
http://dx.doi.org/10.1186/1471-2180-14-181
work_keys_str_mv AT pengfan characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT mizhiqiang characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT huangyong characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT yuanxin characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT niuwenkai characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT wangyahui characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT huayuhui characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT fanhuahao characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT baichangqing characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates
AT tongyigang characterizationsequencingandcomparativegenomicanalysisofvbabamimeab2anovellyticbacteriophagethatinfectsmultidrugresistantacinetobacterbaumanniiclinicalisolates